Merck | MRK - Текущие активы





Текущие активы Изменить Дата
Adidas EUR 12.83B 546M 2026-06
Adyen EUR 13.97B 2.28B 2026-06
Akzo Nobel EUR 8.41B 287M 2026-09
Alcon AG USD 6.62B 4M 2026-06
Amadeus IT EUR 2.64B 324.6M 2026-06
Amarin USD 612.88M 10.12M 2026-09
AstraZeneca USD 27.97B 1.65B 2026-06
BASF EUR 35.21B 3.58B 2026-09
Bayer EUR 33.64B 1.66B 2026-06
Beiersdorf EUR 7.43B 768M 2026-06
Covestro EUR 5.91B 259M 2025-12
Danone EUR 16.06B 2.83B 2026-06
Fresenius EUR 11.61B 456M 2026-06
Fresenius Medical Care EUR 7.69B 418.66M 2026-06
Genmab DKK 2.8B 228M 2026-06
Givaudan CHF 4.07B 258M 2025-12
GlaxoSmithKline GBP 17.9B 336M 2026-09
GRIFOLS EUR 5.31B 51M 2026-06
Henkel EUR 11.93B 1.86B 2026-06
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Infineon EUR 10.29B 234M 2026-06
Lakefront Biotherapeutics EUR 2.31B 751.38M 2026-06
Linde USD 12.75B 574M 2026-03
Lonza CHF 8B 3.41B 2025-12
Merck EUR 13.77B 393M 2026-06
Novartis USD 27.35B 744M 2026-06
Philips EUR 9.33B 454M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
UCB EUR 6.05B 733M 2025-12